Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MALVERN, Pa., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the pricing of its public offering of an aggregate of 11,819,172 shares of its common stock (or pre-funded warrants in lieu thereof), together with accompanying common stock purchase warrants, at a public offering price of $0.525 per share (or pre-funded warrant) and accompanying warrants. Each share of common stock (or pre-funded warrant) was sold in the offering together with a Series A-1 warrant to purchase one share of common stock at an exercise price of $0.525 per share and a Series A-2 warrant to purchase one share of common stock at an exercise price of $0.525 per share. The Series A-1 warrants are exercisable immediately and will expire five years from the date of issuance, and the Series A-2 warrants are exercisable immediately and will expire thirteen months from the date of issuance. The closing of the offering is expected to occur on or about September 1, 2022, subject to the satisfaction of customary closing conditions.
https://finance.yahoo.com/news/baudax-bio-announces-pricing-6-020400632.html
$GSAT long 1.91. Caught this one late but looks like the trend is holding up.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815730
I'll be watching the charts. They ran this puppy up right when they announced the new warrant pricing. Shorts FOR SURE took advantage. Which they'll want to cover when one of the fundamental shoes drop on top of them. As this comes together on the technical side the chess pieces could set up nicely. Of course the right news to push this back over the $ can come anytime.
Just FYI, I'm more of a swing player but I tend to stick to holdings that look worth the risk. Which is why I'm still holding some here and watching to add.
All imo.
btw, just added .545's. May have been more of just wanting a better (stronger) position.
See if it can pick up the momentum into the close.
I should have been keeping an eye on this months ago.
They could be granted a new 180 day extension. Another one I hold was just granted one.
I think this warrants time which is exactly what they need.
And the warrant thing signifying a RS is only my opinion.
https://ih.advfn.com/stock-market/NASDAQ/dynatronics-DYNT/stock-news/88926630/current-report-filing-8-k
Changing the warrants as low as they did imo was like raising a white flag for a potential reverse split. Long term looks promising as long as the science holds. Need to regain compliance and avoid the RS. But, I think we're a few months from that happening. I posted their new slide show last week, should be a few posts back. They've done quite a bit to streamline and vut the burn rate. Now it's a matter of time. I haven't predidcted a real price going forward, once they get a bit more solid FDA acceptance I'll certainly be paying more attention.
Good luck!
Took 1.91. See if this does show continuation.
Energous (WATT)'s Technical Outlook is Bright After Key Golden Cross
https://finance.yahoo.com/news/energous-watt-technical-outlook-bright-135501858.html
The 50 is setting up to cross over the 200. That's my definition of a true golden cross. IMO, it looks more like WATT is about to head for lower support. right near where the 50/200 is setting up to cross. Around 1.16 or so.
EDIT: Watching 1.97 here for support. $GSAT....
Nope. Not going to cut resistance looks like. Fundamentals look pretty good though.
$GSAT $2.02 showing potential continuation. Looking to enter the power zone.
Gap filled. Eom
.575 Fills the gap. eom.
Thanks for the alert yesterday!! FRTG looking PURDY!!!
I just happened t stalk you guys here yesterday and the chart was too tempting to pass up!! Took all the .036's I could get.
Cheers!
Compliance extended to Feb 23, 2023.
Time to get back over the $$!!
https://ih.advfn.com/stock-market/NASDAQ/dynatronics-DYNT/stock-news/88926630/current-report-filing-8-k
Sold the rest out of my regular account but kept a few in the IRA.. They restructured the warrants so their "buddies" ran this up for them to re-short and make a few bucks. I'm thinking this will still be a nice long and will profit from their pipeline.
Watching for this to settle again.
All IMO of course.
Sold half 1.10, riding to see what happens.
LII's are wide awake. Early volume.
This is the AIM I see...
AIM
Bid: 0.70 Ask: 0.7089 Last: 0.7001 Chg ($): -0.0025 Vol: 20.03K
https://finviz.com/quote.ashx?t=AIM
Just stumbled on this one Mick. “The actions of AIM are a desperate attempt and part of a troubling pattern of AIM CEO Tom Equels and directors William Mitchell and Stewart Appelrouth wasting corporate assets at the expense of stockholders to do whatever it takes to ensure that they run unopposed, including crafting up ‘conspiracy theories’ in their effort to retain control and enrich themselves and deny stockholders basic rights to nominate alternative directors, solely to keep their gravy-train of excessive compensation going,” stated Mr. Jorgl. “We are very pleased that the court has set the earliest date possible for expedited proceedings on our matter, which we expect will result in our nominations being allowed.”
Haven't even really started my DD and the first thing that caught my eye was drama!
https://finance.yahoo.com/news/aim-stockholder-full-value-committee-200500232.html
This could get interesting. Going to do some digging and put this on radar.
And now I own a lot of shares.
Just some FYI...
https://finviz.com/quote.ashx?t=BXRX&p=m&tas=0
Float 6.03M.
Aug 23 Presentation
https://d1io3yog0oux5.cloudfront.net/_901ee2762ab0a9fe74fbbb597524e7cc/baudaxbio/db/227/1543/pdf/BXRX+August+Corporate+Presentation.8.23.22.Final.pdf
https://www.baudaxbio.com/news-and-investors/presentations
Two novel NMBs & a novel reversal agent in development
•Neuromuscular blocking agents–BX1000: Intermediate acting agent duration of action (~45 mins*)
•Rapid onset•Completed one Dose escalation clinical trial; Phase 2 surgical trial expected to commence in 2022
–BX2000: Ultra-short acting agent duration of action (10-15 mins*)
•Rapid onset
•Dosing completed for the second cohort of Phase 1 clinical study evaluating the safety,tolerability and pharmacokinetics in healthy volunteers
•Novel reversal agent
–Specific for BX1000 and BX2000; provides complete chemical reversal ofneuromuscular blockade from any depth of block within 2-5 minutes*
•In pre-clinical development; expect to file IND in the first half of 2023
burn rate was reduced by approximately 65% going forward
On the technical side bottom may be getting closer. Though a lower low is still a lower low, it MAY be worth the risk for a piece.
IMO of course.
And yes, I do own shares of BXRX.
Noble Financial analyst Gregory Aurand maintained a Buy rating on Baudax Bio (BXRX - Research Report) today and set a price target of $3.25. The company's shares closed yesterday at $0.68.According to TipRanks, Aurand is an analyst with an average return of -20.9% and a 28.57% success rate. Aurand covers the Healthcare sector, focusing on stocks such as BioSig Technologies, Baudax Bio, and Ortho Regenerative Technologies.Currently, the analyst consensus on Baudax Bio is a Moderate Buy with an average price target of $3.25.See the top stocks recommended by analysts >>The company has a one-year high of $26.63 and a one-year low of $0.67.
https://www.tipranks.com/news/blurbs/noble-financial-keeps-their-buy-rating-on-baudax-bio-bxrx?utm_source=advfn.com&utm_medium=referral
As it prints a new 52 WK low.
Last | 1:37 PM EDT
33,089.64
quote price arrow down - 617.10 (-1.83%)
Volume
154,461,689
52 week range
29,653.29 - 36,952.65
Crazy.
Good bye summer!!
Inpixon Achieves FCC, ISED Certifications and Establishes CE Status for Inpixon Swarm Chirp V3
https://finance.yahoo.com/news/inpixon-achieves-fcc-ised-certifications-133000511.html
Thought this would see more volume.
Looks like the ingredients are on the bottle. Not that I'd even buy a bottle.
https://www.amazon.com/Essential-Synthesis-improving-Recovery-Endurance/dp/B07NK1VDXT/ref=sr_1_6?crid=1ARRV2YM5QSXH&keywords=essential+9+amino+acids&qid=1660931981&sprefix=esential+9%2Caps%2C141&sr=8-6
Wonder if they've even actually sold any.
Just need the right news on the right day.
$1+++
I've followed cfrx for a while. Keeping my swings pretty tight. Already out one account with only around 15%. Still have some do or die in the IRA. They still may let it go a bit.
Agree on the fundamental side could still have a hail Marry in it..
Good luck!
CFRX .304.
CFRX
Pinch looks very close imo. We'll see.
Nice to see the volume maintaining. Hope some were able to take advantage advantage of the dip.
Looking good!
Nice!! Get'r done LXRX!
This has just been one of those summers where everything is ut of whack. "They" say, "the market knows". But I think we'll know once summer ends. Recession or not I think DYNT and many others will show some life starting in September.
Couldn't pass up adding more. Pinch this puppy!!
CFRX daily
CFRX .3031. About as tight a pincher one could ask for. IMO of course.
CFRX daily
Looks like the selling is close to being oversold.
This puppy should be around $5 imo.
Very good news.
ADX & PPO coming together slowly.
It'll get there!
Finviz Target Price 3.88.
Actually, I was surprised to find there's very little short interest according to finviz.
Short Float 1.40% of a rather small float of Shs Float 42.82M. I still think this has a very good chance of getting back over the $.
Insiders accumulated: Insider Trans +51.41%
https://finviz.com/quote.ashx?t=SNGX
This'll get there imo. Doubt institutional interest will stay on the sidelines much longer.
Shorts trying to hold this back imo.